1st Edition
DNA- and m-RNA-Based Vaccines An Immunotherapeutic Approach to Cancer
Foreword
Preface
1. Various Prospects of Tumor Angiogenesis
2. Cancer Treatment Through Gene Therapy: Methods, Challenges, and Current Progress
3. Current Status and Prospects for Cancer Gene Therapy
4. Therapeutic Interventions and Non-Coding RNA-Mediated Mechanisms of Cancer Resistance
5. The Role of Splicing as a Therapeutic Target of Cancer
6. Cancer DNA Vaccines: Inducing Efficient Immunity
7. Innovative DNA Vaccines That Utilize Pinpoint Precision Technology to Effectively Stimulate the Immune System Against Cancer
8. Utilizing DNA Vaccines and Electroporation to Fight Cancer
9. Promoting DNA-Based Cancer Vaccine Research
10. Cancer Immunotherapy Using a DNA Vaccination
11. Cancer Vaccine Based on Plasmid DNA and Messenger RNA
Biography
Sonali Sundram, MPharm, is an Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, India. She was previously affiliated as a research scientist with the Indian Council of Medical Research at King George’s Medical University and with S Babu Banarasi Das Northern India Institute of Technology, both in India. Her PhD (Pharmacy) work is in neurodegeneration and nanoformulation. Her areas of interest include neurodegeneration, clinical research, and artificial intelligence. She has edited several books and has organized more than 15 national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit.
Rishabha Malviya, PhD, has 15 years of research experience. He is a Professor of Pharmacy, School of Medical and Allied Sciences, Galgotias University, India. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. He has authored more than 300 research and review papers for national and international journals and has 58 patents to his name. He has also published edited books and authored 170 book chapters. He is included in the list of the World’s Top 2% Scientists (2020, 2021, 2022, 2023 and 2024) by Elsevier BV and Stanford University. He is reviewer, editor, and editorial board member for more than 50 national and international journals.
